Investigate the Presence of HBV Surface Antigen in Pregnant Women, Cairo City in Egypt

Document Type : Original Articles

Authors

1 Al-Manara College for Medical Sciences, Maysan, Iraq

2 University of Al-Ameed, College of Pharmacy, Karbala, Iraq

3 The University of Mashreq, Baghdad, Iraq

4 College of MLT, Ahl Al Bayt University, Kerbala, Iraq

5 Consultant Internist and Cardiologist, College of Medical Technology, Al-Farahidi University, Baghdad, Iraq

6 Medical Laboratories Techniques Department, Al-Mustaqbal University College, Babylon, Iraq

7 Anesthesia Techniques, Al–Nisour University College, Baghdad, Iraq

8 Department of Pharmacy, Ashur University College, Baghdad, Iraq

9 Research Institute of Medical Entomology RIME, General Organization for Teaching Hospitals and Institutes, GOTHI, Egypt

Abstract

Hepatitis means inflammation of the liver, and hepatitis B is a common and dangerous liver disease caused by the Hepatitis B Virus (HBV) of the DNA hepadnavirus family. In 2010, the World Health Organization (WHO) considered hepatitis B infection a major health problem worldwide. One way of transmitting this disease is a transmission from a carrier mother to a child. This study aimed to investigate the presence of HBV surface antigen in pregnant women referred to Kasra Al-Aini Hospital in Cairo. This study was a cross-sectional descriptive study that was performed on pregnant women. One thousand pregnant women were selected with their consent to participate in this study, and after preparing a blood sample, an Enzyme-linked Immunosorbent Assay kit, used for Hepatitis B Virus surface antigen detection, a questionnaire containing questions about socio-individual characteristics. Among 1000 samples, 13 samples were equal to 1.3% had HBsAg positive. No significant relationship was found between the prevalence of HBs Ag in the city and rural location, education, occupation, age, and history of abortion in pregnant women. History of dialysis in pregnant women, tattooing, and type of job of the pregnant woman was not considered risk factors. However, injection drug users, history of previous surgery, and blood transfusion can be considered suspicious factors (P≤0.05). The prevalence of hepatitis B infection in pregnant women in Cairo was 1.3, which is lower than the study statistics in most parts of the world. However, to evaluate this amount more accurately, there is a need to conduct a study with a higher sample size.

Keywords

References

  1. Ling SC, Lin HS, Murray KF, Rosenthal P, Mogul D, Rodriguez-Baez N, et al. Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada. J Pediatr. 2021;237:24-33.
  2. Pape S, Snijders R, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol. 2022;76(4):841-9.
  3. Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJF, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol. 2022;7(8):724-35.
  4. Niesert S, Messner U, Tillmann HL, Gunter HH, Schneider J, Manns MP. [Prevalence of hepatitis B in pregnancy and selective screening]. Geburtshilfe Frauenheilkd. 1996;56(6):283-6.
  5. Al Awaidy S, Abu-Elyazeed R, Al Hosani H, Al Mulla A, Al Busaiedy S, Al Amiry A, et al. Sero-epidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect. 2006;52(3):202-6.
  6. Alvarez-Muñoz MT, Vázquez-Rosales JG, Torres-López FJ, Arredondo-García JL, Bustamante-Calvillo ME, Del Rey-Pineda G, et al. Infection of pregnant women with hepatitis B and C viruses and risks for vertical transmission. Arch Med Res. 1997;28(3):415-9.
  7. Dekker SE, Green EW, Ahn J. Treatment and Prevention of Acute Hepatitis B Virus. Clin Liver Dis. 2021;25(4):711-24.
  8. Khemichian S, Kahn J, Terrault NA. Use of Hepatitis B Virus-Positive Organs in Organ Transplantation. Clin Liver Dis. 2021;25(4):841-57.
  9. Papaevangelou V, Hadjichristodoulou C, Cassimos D, Theodoridou M. Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC Infect Dis. 2006;6:84.
  10. Khalil MK, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdi YS, Mishkhas A, Bakhsh M, et al. Serosurvey of hepatitis B surface antigen in pregnant Saudi women. East Mediterr Health J. 2005;11(4):640-7.
  11. Roberts SK, Majeed A, Kemp W. Controversies in the Management of Hepatitis B: Hepatocellular Carcinoma. Clin Liver Dis. 2021;25(4):785-803.
  12. Uyar Y, Cabar C, Balci A. Seroprevalence of hepatitis b virus among pregnant women northern turkey. Hepat Mon. 2009;9(2 (23)):-.
  13. Netanel C, Ben-Aharon O, Ben-Ari Z, Chodick G, Anis E, Magnezi R. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016. Vaccine. 2021;39(48):7101-7.
  14. Vazquez-Martinez JL, Coreno-Juarez MO, Montano-Estrada LF, Attlan M, Gomez-Dantes H. Seroprevalence of hepatitis B in pregnant women in Mexico. Salud Publica Mex. 2003;45(3):165-70.
  15. Lee WC, Chen TK, Han HF, Lin YC, Hwang YM, Kao JH, et al. Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan. J Microbiol Immunol Infect. 2021;54(5):901-8.
  16. Salleras L, Dominguez A, Bruguera M, Plans P, Espunes J, Costa J, et al. Seroepidemiology of hepatitis B virus infection in pregnant women in Catalonia (Spain). J Clin Virol. 2009;44(4):329-32.
  17. Lesi OA, Ward JW. Paving the way towards hepatitis B virus-free generations in Africa. The Lancet Global health. 2021;9(11):e1491-e2.
  18. Riveiro-Barciela M, Pericas JM, Buti M. How to interpret viral markers in the management of chronic hepatitis B infection. Clin Microbiol Infect. 2022;28(3):355-61.
  19. Razavi H. Global Epidemiology of Viral Hepatitis. Gastroenterol Clin North Am. 2020;49(2):179-89.
  20. Seto MT, Cheung KW, Hung IFN. Management of viral hepatitis A, C, D and E in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2020;68:44-53.
  21. Khuroo MS, Sofi AA. The Discovery of Hepatitis Viruses: Agents and Disease. J Clin Exp Hepatol. 2020;10(4):391-401.
  22. Deerin JF, Clifton R, Elmi A, Lewis PE, Kuo I. Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018. Vaccine. 2021;39(15):2094-102.
  23. Bertolini DA, Pinho JR, Saraceni CP, Moreira RC, Granato CF, Carrilho FJ. Prevalence of serological markers of hepatitis B virus in pregnant women from Parana State, Brazil. Braz J Med Biol Res. 2006;39(8):1083-90.
  24. Lin CC, Hsieh HS, Huang YJ, Huang YL, Ku MK, Hung HC. Hepatitis B virus infection among pregnant women in Taiwan: comparison between women born in Taiwan and other southeast countries. BMC Public Health. 2008;8:49.
  25. Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, et al. Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J. 2006;83(9):485-93.
  26. Khattab MA, Eslam M, Sharwae MA, Hamdy L. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008. Am J Infect Control. 2010;38(8):640-1.
  1. Abdelmawla D, Moemen D, Darwish A, Mowafy W. Hepatitis E virus prevalence in Egyptian children with transfusion-dependent thalassemia. Braz J Infect Dis. 2019;23(1):40-4.
Archives of Razi Institute
Volume 77, Issue 5 - Serial Number 5
September and October 2022
Pages 1909-1916

Files

Share

How to cite

Statistics